Gilead Sciences, Inc. (GILD) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gilead Sciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.978 Good afternoon, everyone, and welcome to Gilead's first quarter 2026 earnings conference 00:00:04.978 -- 00:00:08.303 call. My name is Rebecca, and I'll be today's host. 00:00:08.303 -- 00:00:11.767 In a moment, we'll begin our prepared remarks, followed by our Q&A session. 00:00:11.767 -- 00:00:16.634 Please note that the process for queuing questions has changed this quarter. 00:00:16.634 -- 00:00:21.341 To ask a question, press star 1, and to withdraw your question, press star 1 again. 00:00:21.341 -- 00:00:26.468 Now, I'll hand the call over to Jackie Ross, Senior Vice President, Treasurer, and 00:00:26.468 -- 00:00:29.389 Head of Investor Relations. 00:00:29.562 -- 00:00:34.647 Thank you, Rebecca. Just after market closed today, we issued a press release with earnings 00:00:34.647 -- 00:00:38.171 results for the first quarter of 2026. The 00:00:38.171 -- 00:00:42.776 press release, slides, and supplementary data are available on the investor section of 00:00:42.776 -- 00:00:45.797 our website at Gilead.com. 00:00:45.919 -- 00:00:50.204 The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel 00:00:50.204 -- 00:00:55.489 O'Day, our Chief Commercial and Corporate Affairs Officer, Joanna Mercier, our Chief 00:00:55.489 -- 00:01:01.358 Medical Officer, Dietmar Berger, and our Chief Financial Officer, Andrew Dickinson. 00:01:01.358 -- 00:01:05.925 After that, we'll open the call to Q&A, where the team will be joined by Cindy Peretti, 00:01:05.925 -- 00:01:09.250 the Executive Vice President of KITE. 00:01:09.250 -- 00:01:13.075 Let me remind you that we will be making forward-looking statements. 00:01:13.075 -- 00:01:18.183 Please refer to slide two regarding the risks and uncertainties relating to forw...